JP2007522135A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007522135A5 JP2007522135A5 JP2006551595A JP2006551595A JP2007522135A5 JP 2007522135 A5 JP2007522135 A5 JP 2007522135A5 JP 2006551595 A JP2006551595 A JP 2006551595A JP 2006551595 A JP2006551595 A JP 2006551595A JP 2007522135 A5 JP2007522135 A5 JP 2007522135A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- independently
- subject
- electron withdrawing
- withdrawing group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54068804P | 2004-01-30 | 2004-01-30 | |
| US63245604P | 2004-12-02 | 2004-12-02 | |
| PCT/US2005/003183 WO2005074598A2 (en) | 2004-01-30 | 2005-01-28 | Nitroxyl progenitor compounds and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007522135A JP2007522135A (ja) | 2007-08-09 |
| JP2007522135A5 true JP2007522135A5 (enExample) | 2008-11-27 |
Family
ID=34841107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006551595A Pending JP2007522135A (ja) | 2004-01-30 | 2005-01-28 | ニトロキシル前駆化合物および使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20090281067A1 (enExample) |
| EP (1) | EP1718621A4 (enExample) |
| JP (1) | JP2007522135A (enExample) |
| AU (1) | AU2005209843B2 (enExample) |
| CA (1) | CA2554771A1 (enExample) |
| WO (1) | WO2005074598A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040038947A1 (en) | 2002-06-14 | 2004-02-26 | The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services | Method of treating ischemia/reperfusion injury with nitroxyl donors |
| US6936639B2 (en) | 2002-08-21 | 2005-08-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitroxyl progenitors in the treatment of heart failure |
| US20090281067A1 (en) | 2004-01-30 | 2009-11-12 | The John Hopkins University | Nitroxyl progenitor compounds and methods of use |
| WO2007002444A1 (en) * | 2005-06-23 | 2007-01-04 | Johns Hopkins University | Thiol-sensitive positive inotropes |
| BRPI0708804B8 (pt) * | 2006-03-17 | 2021-05-25 | Cardioxyl Pharmaceuticals Inc | compostos derivados de n-hidroxilsulfonamida como doadores de nitroxil, composição farmacêutica e kit |
| SG185255A1 (en) | 2007-09-26 | 2012-11-29 | Univ Johns Hopkins | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| AU2009210484A1 (en) * | 2008-02-08 | 2009-08-13 | Merck Sharp & Dohme Corp. | Angiotensin II receptor antagonists |
| US20110160200A1 (en) | 2009-11-23 | 2011-06-30 | Cardioxyl Pharmaceuticals, Inc. | Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension |
| MX356796B (es) * | 2009-12-07 | 2018-06-14 | Cardioxyl Pharmaceuticals Inc | Derivados de hidroxilamina bis-acilados. |
| CN105919987B (zh) | 2009-12-07 | 2020-04-03 | 约翰斯霍普金斯大学 | N-酰氧基磺酰胺和n-羟基-n-酰基磺酰胺衍生物及其用途 |
| CN103476744A (zh) * | 2011-01-19 | 2013-12-25 | 默沙东公司 | 二醇二氮烯鎓衍生物 |
| AU2013201929B2 (en) | 2011-10-17 | 2015-07-23 | The Johns Hopkins University | N-substituted hydroxylamine derivatives with carbon-based leaving groups |
| TWI619491B (zh) | 2013-01-18 | 2018-04-01 | 卡爾迪奧克斯爾製藥公司 | 包含硝醯基予體的醫藥組合物 |
| EP3126329B1 (en) | 2014-01-17 | 2019-05-29 | Cardioxyl Pharmaceuticals Inc. | N-hydroxymethanesulfonamide nitroxyl donors |
| EP3148983A1 (en) | 2014-05-27 | 2017-04-05 | The Johns Hopkins University | N-hydroxylamino-barbituric acid derivatives as nitroxyl donors |
| ES2749682T3 (es) | 2014-05-27 | 2020-03-23 | Cardioxyl Pharmaceuticals Inc | Derivados de pirazolona como donadores de nitroxilo |
| US9464061B2 (en) | 2014-05-27 | 2016-10-11 | The Johns Hopkins University | N-hydroxylamino-barbituric acid derivatives |
| US10723704B2 (en) | 2015-10-19 | 2020-07-28 | Cardioxyl Pharmaceuticals, Inc. | Pyrazolone derivatives as nitroxyl donors |
| JP6957459B2 (ja) | 2015-10-19 | 2021-11-02 | カルディオキシル ファーマシューティカルズ，インク． | ニトロキシルドナーとしてのｎ−ヒドロキシルスルホンアミド誘導体 |
| US10913728B2 (en) | 2016-07-28 | 2021-02-09 | The Johns Hopkins University | O-substituted hydroxamic acids |
| WO2018128999A1 (en) | 2017-01-03 | 2018-07-12 | Cardioxyl Pharmaceuticals, Inc. | Method of administering nitroxyl donating compounds |
| US12577240B2 (en) | 2020-07-11 | 2026-03-17 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| WO2025043108A1 (en) | 2023-08-23 | 2025-02-27 | Bristol -Myers S Quibb Company | Co-crystals of nitroxyl donating compounds |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4369172A (en) | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
| DE3583799D1 (de) | 1985-01-11 | 1991-09-19 | Abbott Lab Ltd | Feste zubereitung mit langsamer freisetzung. |
| US4954526A (en) * | 1989-02-28 | 1990-09-04 | The United States Of America As Represented By The Department Of Health And Human Services | Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents |
| US5039705A (en) * | 1989-09-15 | 1991-08-13 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
| JP2773959B2 (ja) | 1990-07-10 | 1998-07-09 | 信越化学工業株式会社 | 大腸内放出性固形製剤 |
| DE69223157T2 (de) * | 1991-09-24 | 1998-06-10 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Bethesda, Md. | Sauerstoff-substituierte derivate von nucleophil-stickstoffoxid-addukten und ihre verwendung als stickstoffoxid-donor-prodrugs |
| US6200558B1 (en) * | 1993-09-14 | 2001-03-13 | The United States Of America As Represented By The Department Of Health And Human Services | Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| US5632981A (en) | 1992-08-24 | 1997-05-27 | The United States Of America As Represented By The Department Of Health And Human Services | Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| US5700830A (en) * | 1994-11-22 | 1997-12-23 | The United States Of America As Represented By The Department Of Health And Human Services | Use of nitric oxide-releasing agents for reducing metastasis risk |
| CA2266908C (en) * | 1996-09-27 | 2010-07-20 | Joseph E. Saavedra | O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| US5958427A (en) | 1996-11-08 | 1999-09-28 | Salzman; Andrew L. | Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications |
| JP4856295B2 (ja) * | 1997-07-03 | 2012-01-18 | アメリカ合衆国政府 | 新規な一酸化窒素放出アミジン誘導ジアゼニウムジオレート及びその組成物 |
| UA73092C2 (uk) | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
| EP1101490B1 (en) | 1998-07-28 | 2005-04-13 | Tanabe Seiyaku Co., Ltd. | Preparation capable of releasing drug at target site in intestine |
| EP1399164B1 (de) * | 2001-06-05 | 2005-01-26 | Basf Aktiengesellschaft | Metallsalze als antimykotika |
| WO2003006427A1 (en) * | 2001-07-12 | 2003-01-23 | Johns Hopkins University | Compounds that release nitric oxide at controlled rates upon photolysis |
| CA2478867A1 (en) * | 2002-03-15 | 2003-09-25 | Btg International Limited | Formulations of anthraquinone derivatives |
| WO2003080039A1 (en) * | 2002-03-21 | 2003-10-02 | The University Of Utah Research Foundation | In vivo use of glutathionone s-transferase activated nitric oxide donors |
| US20040038947A1 (en) * | 2002-06-14 | 2004-02-26 | The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services | Method of treating ischemia/reperfusion injury with nitroxyl donors |
| US6936639B2 (en) * | 2002-08-21 | 2005-08-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitroxyl progenitors in the treatment of heart failure |
| US20050009789A1 (en) * | 2003-05-13 | 2005-01-13 | The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Service | Cyclooxygenase inhibition with nitroxyl |
| US20090281067A1 (en) | 2004-01-30 | 2009-11-12 | The John Hopkins University | Nitroxyl progenitor compounds and methods of use |
-
2005
- 2005-01-28 US US10/587,644 patent/US20090281067A1/en not_active Abandoned
- 2005-01-28 WO PCT/US2005/003183 patent/WO2005074598A2/en not_active Ceased
- 2005-01-28 EP EP05726388A patent/EP1718621A4/en not_active Withdrawn
- 2005-01-28 JP JP2006551595A patent/JP2007522135A/ja active Pending
- 2005-01-28 CA CA002554771A patent/CA2554771A1/en not_active Abandoned
- 2005-01-28 AU AU2005209843A patent/AU2005209843B2/en not_active Ceased
-
2014
- 2014-09-22 US US14/492,741 patent/US10273202B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007522135A5 (enExample) | ||
| JP2005528393A5 (enExample) | ||
| JP2019094345A5 (enExample) | ||
| JP2019524883A5 (enExample) | ||
| JP2012529486A5 (enExample) | ||
| JP2006501295A5 (enExample) | ||
| JP2005521713A5 (enExample) | ||
| JP2005539088A5 (enExample) | ||
| JP2009537559A5 (enExample) | ||
| JP2010527985A5 (enExample) | ||
| JP2005508337A5 (enExample) | ||
| JP2012512186A (ja) | アミドチアゾール誘導体、その製造方法および使用 | |
| JP2013511556A5 (enExample) | ||
| JP2010248215A (ja) | 筋弛緩促進剤及び筋弛緩不全等の筋組織に係る疾病の治療薬 | |
| JP2010506919A5 (enExample) | ||
| WO2003002554A1 (en) | Piperazine compounds | |
| CN104010636A (zh) | 三环化合物、包含它们的组合物及其用途 | |
| JP2006524252A5 (enExample) | ||
| JP2020111571A5 (enExample) | ||
| CN101134745A (zh) | 一氧化氮供体型替米沙坦衍生物、制备方法及其医药用途 | |
| JP2009040767A5 (enExample) | ||
| JP2010504321A5 (enExample) | ||
| JP2009537532A5 (enExample) | ||
| JPWO2022221227A5 (enExample) | ||
| JP2004517151A5 (enExample) |